Here is the latest stock price and chart of Sun Pharma. For more details, see the Sun Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.
Get Details: We are Bullish on These 3 Little-known Stocks
Live BSE Quotes | Jan 22, 2021 (Close) | ||
---|---|---|---|
Price (Rs)575.05 | Open (Rs) 583.00 | High (Rs) 586.95 | Low (Rs) 570.65 |
% Change-1.34 | Volume 188,429 | Value (Rs) 109,143,691 | 52-Week H/L 627.95 / 315.20 |
Live NSE Quotes | Jan 22, 2021 (Close) | ||
---|---|---|---|
Price (Rs)575.20 | Open (Rs) 582.90 | High (Rs) 586.95 | Low (Rs) 570.60 |
% Change-1.32 | Volume 5,591,688 | Value (Rs) 3,216,338,938 | 52-Week H/L 628.00 / 312.00 |
Change | |||||
---|---|---|---|---|---|
1 Day -1.34% | 1 Month 1.22% | 3 Months 18.41% | 1 Year 28.86% | 5 Years (CAGR)* -6.16% | 10 Years (CAGR)* 9.03% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 4.31 | P/E Ratio (x) 133.51 | Market Cap (Rs m) 1,384,003.31 | P/BV (x) 3.06 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
SUN PHARMA last traded price was down 1.3% to Rs 575.1 on the BSE. On the NSE, SUN PHARMA last traded price was down 1.3% to Rs 575.2. The total volume of shares traded was 5.8 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 1.2%. And the benchmark S&P BSE SENSEX was at 48,878.5 (down 1.5%).
Over the last 30 days, the SUN PHARMA share price is up 4.2%. And over the last one year, SUN PHARMA share price is up 28.5%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed huge selling pressure today and extended losses as the session progressed, dragged down by heavy selling in metal and banking stocks.
Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.
For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.
For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.
Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More